Epidemiology and Health

Original Articles

The coverage rates for influenza vaccination and related factors in Korean adults aged 50 and older with chronic disease: based on 2016 Community Health Survey data: Kyeong Hyang Byeon, Jaiyong Kim, Boyoung Choi, Bo Youl Choi; Epidemiol Health. 2018;40:e2018034. Published online July 24, 2018; DOI: https://doi.org/10.4178/epih.e2018034

11,130 View
217 Download
14 Citations

Abstract Summary PDF Supplementary Material

Abstract

OBJECTIVES
This study aims to identify the coverage rates for influenza vaccination and related factors depending on chronic disease in Korean adults aged 50 and older.

METHODS

The 2016 Korea Community Health Survey was used for analysis. Chi-square test was performed to investigate the coverage rates for influenza vaccination depending on chronic disease, and a multiple logistic regression analysis was used to identify the factors associated with influenza vaccination, by chronic disease.

RESULTS

In men with ≥1 chronic disease, 39.8% of 50-64 years of age, and 86.8% of elderly (over 65 years of age) received influenza vaccination. In women with ≥1 chronic disease, 58.7% of 50-64 years of age, and 89.9% of elderly (over 65 years of age) received influenza vaccination (p<0.001). The chronic diseases associated with influenza vaccination were hypertension (odds ratio [OR], 1.27; 95% confidence interval [CI], 1.19 to 1.37), diabetes (OR, 1.41; 95% CI, 1.28 to 1.55) in men aged 50-64, hypertension (OR, 1.34; 95% CI, 1.20 to 1.49), diabetes (OR, 1.17; 95% CI, 1.02 to 1.33), chronic cardiovascular disease (OR, 1.31; 95% CI, 1.07 to 1.60) in elderly (over 65 years of age). In women aged 50-64, hypertension (OR, 1.39; 95% CI, 1.30 to 1.49), diabetes (OR, 1.51; 95% CI, 1.35 to 1.68), chronic cardiovascular disease (OR, 1.31; 95% CI, 1.05 to 1.64), and hypertension (OR, 1.55; 95% CI, 1.40 to 1.71), diabetes (OR, 1.27; 95% CI, 1.12 to 1.43) in elderly (over 65 years of age).

CONCLUSIONS

Populations in aged 50-64 are recommendation subject for vaccination or classified as high-risk group in case with chronic disease. Though subject over 60 years old is age close to the elderly, the coverage rates for vaccination was low. It is necessary to devise strategies to raise the coverage rates for vaccination.

Summary

Korean summary
매년 인플루엔자 환자수는 증가하는 추세이며 인플루엔자로 인한 의료이용의 질병부담은 커질 것으로 생각된다. 국내에서는 우선접종 권장대상자들에게 예방접종을 받도록 권고하고 있으며, 예방접종은 인플루엔자를 예방할 수 있는 비용 효과적인 방법이다. 65세 이상 대상자는 국가 무료 예방접종 사업 대상으로 인해 예방접종률이 높은 것으로 확인되었다. 50-64세 인구는 예방접종 권고 대상자임에도 불구하고 낮은 것으로 나타났고, 50-64세 연령에서 만성질환을 동반할 경우 고위험군이지만 여전히 낮은 예방접종률을 보였다. 또한 50-64세 연령에서 1개 이상 만성질환을 동반할 경우 대도시, 중소도시에 거주하는 것보다 군지역에 거주할 경우 높은 예방접종률을 확인함으로써 대도시 및 중소도시에 거주하는 50-64세 연령에 대해 예방접종률을 올릴 수 있는 적극적인 예방접종 홍보가 필요할 것으로 생각한다.

Citations

Citations to this article as recorded by

All-Cause and Cause-Specific Mortality Attributable to Seasonal Influenza: A Nationwide Matched Cohort Study
Heeseon Jang, Jaelim Cho, Seong-Kyung Cho, Donghan Lee, Sung-il Cho, Sang-Baek Koh, Dong-Chun Shin, Changsoo Kim
Journal of Korean Medical Science.2023;[Epub] CrossRef
Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years
Min Joo Choi, Gyeongseon Shin, Daewon Kang, Jae-Ok Lim, Yun-Kyung Kim, Won Suk Choi, Jae-Won Yun, Ji Yun Noh, Joon Young Song, Woo Joo Kim, Sang-Eun Choi, Hee Jin Cheong
Vaccines.2022; 10(3): 445. CrossRef
Assessing Vaccine Protection for Older Adults with Diabetes: A Systematic Review
Leena Almasri, Barbara J. Holtzclaw
Western Journal of Nursing Research.2022; 44(6): 582. CrossRef
Drivers of and barriers to routine adult vaccination: A systematic literature review
Amanda L. Eiden, Jane Barratt, Mawuli K. Nyaku
Human Vaccines & Immunotherapeutics.2022;[Epub] CrossRef
Factors associated with influenza vaccination coverage and willingness in the elderly with chronic diseases in Shenzhen, China
Hongbiao Chen, Qiushuang Li, Minyi Zhang, Zihao Gu, Xiaofeng Zhou, He Cao, Fei Wu, Minyi Liang, Liting Zheng, Juxian Xian, Qing Chen, Qihui Lin
Human Vaccines & Immunotherapeutics.2022;[Epub] CrossRef
The role of health determinants in the influenza vaccination uptake among older adults (65+): a scope review
Regina Roller-Wirnsberger, Sonja Lindner, Lea Kolosovski, Elisabeth Platzer, Peter Dovjak, Holger Flick, Chariklia Tziraki, Maddalena Illario
Aging Clinical and Experimental Research.2021; 33(8): 2123. CrossRef
Factors Related to Influenza Vaccination Intention in University Students Based on Theory of Planned Behavior
Yeojoo Chae, Sunjoo Kim, Seungkyoung Yang
Journal of Health Informatics and Statistics.2021; 46(1): 64. CrossRef
Analysis of Epidemiological and Clinical Characteristics of COVID-19 in Northwest Mexico and the Relationship Between the Influenza Vaccine and the Survival of Infected Patients
Uriel A. Angulo-Zamudio, Francisco M. Martínez-Villa, Nidia Leon-Sicairos, Hector Flores-Villaseñor, Jorge Velazquez-Roman, Abraham Campos-Romero, Jonathan Alcántar-Fernández, Francisco Urrea, Secundino Muro-Amador, Julio Medina-Serrano, Jesus J. Martinez
Frontiers in Public Health.2021;[Epub] CrossRef
Influenza Vaccination Coverage among Older Adults with Hypertension in Shenzhen, China: A Cross-Sectional Survey during the COVID-19 Pandemic
Qiushuang Li, Minyi Zhang, Hongbiao Chen, Fei Wu, Juxian Xian, Liting Zheng, Minyi Liang, He Cao, Xiaofeng Zhou, Zihao Gu, Qihui Lin, Qing Chen
Vaccines.2021; 9(10): 1105. CrossRef
A Nationwide Survey on the Hospital Vaccination Policies in Korea
Sun Hee Park, Mi Suk Lee, Sung Ran Kim, Yee Gyung Kwak
Journal of Korean Medical Science.2020;[Epub] CrossRef
Possibilities for Coronavirus (COVID 19) – The Perspectives
Mark Christopher Arokiaraj
SSRN Electronic Journal .2020;[Epub] CrossRef
Correlation of Influenza Vaccination and the COVID-19 Severity
Mark Christopher Arokiaraj
SSRN Electronic Journal .2020;[Epub] CrossRef
Considering Interim Interventions to Control COVID-19 Associated Morbidity and Mortality—Perspectives
Mark Christopher Arokiaraj
Frontiers in Public Health.2020;[Epub] CrossRef
Increasing Influenza Vaccination Rates in People With Chronic Illness
Linda Sanftenberg, Felix Brombacher, Jörg Schelling, Stefanie J. Klug, Jochen Gensichen
Deutsches Ärzteblatt international.2019;[Epub] CrossRef

Preventive Efficacy of Influenza Vaccination against to Influenza-like Illness among Eldery.: Byung Chul Chun, Heung Jeong Woo, Seung Chul Park; Korean J Epidemiol. 1999;21(2):205-219.

5,127 View
34 Download

Abstract PDF: Abstract
BACKGROUND
Influenza is a highly infectious viral illness. The epidemics of influenza occur from the late fall to the early spring nearly every year and are responsible for several hundred thousand death per year all over the world. Influenza vaccine is the primary method for preventing influenza and its more severe complications. The efficacy of influenza vaccination have been well known in developed countries. The influenza vaccination has been recommended as one of the tentative immunization schedule for indicated persons since 1997 in Korea. But there are still no available data about them, even though nearly 5 - 8 million doses of influenza vaccine were used in a winter season. PURPOSE: To assess the clinical efficacy of influenza vaccine against influenza-like illness(ILI) among Korean elderly(age over 65).
METHODS
Primary study design - a prospective field trial. Study subjects and method - We prospectively observed the 1,488 vaccinee and 1,425 non-vaccinee in a community(Nonsan city) from November 1 1998 to March 31 1999. The vaccinee were those who randomly selected 100-200 per 13 sub-region(Myon) in Nonsan city, and the non-vaccinee were those who had not vaccinated until January 1999 among the Nonsan city elderly cohort. This cohort was consisted of 5,787 elderly(over 1/3 of total elderly population) who had ever visited the community health center or 13 public health offices in Nonsan city in 1998. We followed up these two groups two times-in January and April 1999 - by telephone survey. The questionnaire included the questions about the health behaviors, medical history, socioeconomic condition, medical security type, physical function status, medical facility utilization in the season, symptom and signs of influenza-like illness, number and type of the flu, hospitalization or not. We did throat swap to isolate the virus of 490 patient who had influenza -like symptoms in the same period.
RESULTS
Influenza vaccination was significantly reduced the incidence of influenza -like illness(fever or chilling sensation and cough or sore throat) in the vaccinated. The preventive effect of influenza-like illness among influenza risk group was about 32%(95% CI, 20%-44%). The illness duration of main symptoms of influenza-like illness(fever, cough) was significantly shorter in the vaccinee. The consistency of the survey was noted quite high from the analysis of the result of test-retest(104 person).
CONCLUSION
Influenza vaccination significantly reduced the incidence of influenza-like illness(32%) among elderly.; Summary

First
Prev
Page of 1
Next
Last

Search